Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck Still Believes 2 Is Better Than 1
Motley Fool
Monday, January 7, 2013 - 10:19am
tags:
Merck, Zetia, Pfizer, Lipitor
Biogen Idec Retools After ALS Drug Trial Failure
Seeking Alpha
Monday, January 7, 2013 - 10:17am
tags:
ALS, Lou Gehrig's disease, Biogen Idec, dexpramipexole
India set to rule in Novartis patent case
FiercePharma
Saturday, January 5, 2013 - 11:12am
tags:
patent, Novartis, legal, India
UCSD biotech spinoff snags $18M A round to advance RNAi drugs
FierceMedicalDevice
Saturday, January 5, 2013 - 11:09am
tags:
biotech, funding
Pfizer snaps up 'armed antibody' for autoimmune ailments from biotech
FierceBiotech
Saturday, January 5, 2013 - 11:07am
tags:
Pfizer, biotech
Biotech insider trading case heats up with ex-SAC manager's pleas
FierceBiotech
Saturday, January 5, 2013 - 11:05am
tags:
biotech, insider trading, legal
Pernix Acquires Cypress and Hawthorn
Yahoo/Zacks
Saturday, January 5, 2013 - 11:02am
tags:
Pernix, Cypress Bioscience, Hawthorn, M&A
Allergan Reaches New 52-Week High (AGN)
The Street
Saturday, January 5, 2013 - 11:01am
tags:
Allergan, stock
Gainey & McKenna Announces a Securities Fraud Class Action Lawsuit Has Been Filed Against ISIS Pharmaceuticals, Inc. -- ISIS
Yahoo/GlobeNewswire
Saturday, January 5, 2013 - 11:01am
tags:
Isis Pharmaceuticals, lawsuit, legal, securities fraud
Now Is A Good Time To Buy Dendreon
Seeking Alpha
Saturday, January 5, 2013 - 10:51am
tags:
Dendreon, analysis
Discovery Labs CFO Becomes CEO
The Motley Fool
Saturday, January 5, 2013 - 10:51am
tags:
Discovery Labs, CFO, CEO, Management
Amicus Therapeutics: One Biotech Firm Making Considerable Strides In Terms Of Pompe Disease
Seeking Alpha
Saturday, January 5, 2013 - 10:50am
tags:
Amicus Therapeutics, biotech, Pompe disease
A Leading Biotechnology Company Offering Explosive Growth
The Motley Fool
Saturday, January 5, 2013 - 10:49am
tags:
biotech, Biogen Idec
Abbott Gets Xience Xpedition Approval
Yahoo/Zacks
Saturday, January 5, 2013 - 10:43am
tags:
Abbott Laboratories, Xience Xpedition, regulatory, FDA
AbbVie Declares Inaugural Dividend
Yahoo/PRNewswire
Saturday, January 5, 2013 - 10:42am
tags:
AbbVie, dividend, stock
Are FDA Delays Good or Bad for Investors?
The Motley Fool
Saturday, January 5, 2013 - 10:40am
tags:
FDA, regulatory
Tranzyme Partners with Bristol-Myers, Lilly Fights Patent Cliff: Healthcare Business Recap
Wall Street Cheat Sheet
Saturday, January 5, 2013 - 10:40am
tags:
Tranzyme, Bristol-Myers Squibb, partnerships, Eli Lilly, patent, Healthcare
1 Pharma Hoping Its Pipeline Bears Fruit
The Motley Fool
Saturday, January 5, 2013 - 10:38am
tags:
Eli Lilly, pipelines
Smartphone-enabled prosthetics keep amputees out of the office | MassDevice.com On Call
Mass Device
Friday, January 4, 2013 - 11:51am
tags:
iPhone, prosthetics, technology
Forest Labs Settles BYSTOLIC Patent Lawsuit
Motley Fool
Friday, January 4, 2013 - 11:49am
tags:
Bystolic, patents, Forest Labs, settlements

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.